Prenetics Global
(NASDAQ:PRE)
$3.61
0.12[3.44%]
Last update: 8:18AM Get Real Time Here
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest
62.5%
Overview Rating
Good
Technicals Analysis
66
0100
Financials Analysis
60
0100

Prenetics Global Stock (NASDAQ:PRE), Quotes and News Summary

Prenetics Global Stock (NASDAQ: PRE) stock price, news, charts, stock research, profile.

Open-
Close-
Volume / Avg.215.000 / 75.658K
Day Range- - -
52 Wk Range3.245 - 15.900
Market Cap$44.061M
P/E Ratio0.802
Dividend Yield-
ExchangeNASDAQ
RSI
38
Short Interest
0.13%
Days to Cover1

Recent News

Why StoneCo Shares Are Trading Higher By Over 6%; Here Are 20 Stocks Moving Premarket
StoneCo Ltd. (NASDAQ: STNE) shares rose in pre-market trading after the company reported upbeat results for its third quarter on Friday.
Lisa Levin
EXCLUSIVE: Prenetics, Professor Dennis Lo Aim To Make Early Cancer Detection 'Universally Accessible Necessity' With $200M Joint Venture
Prenetics Global Limited (NASDAQ: PRE), a genomics and precision oncology company, and Professor Dennis Lo announced Sunday they have entered a partnership to establish an early cancer detection screening joint venture, Insighta. 
Bibhu Pattnaik
Relieved Of 'High-Risk' Marker, New Horizon Health Aims To Break Even Next Year
Key Takeaways: New Horizon Health is expected to attract more investors after becoming the seventh Hong Kong biotech stock to shed a designation reserved for high-risk stocks The company’s gross margin has climbed to 84.5% and is expected to remain at 85% to 90% going forward 　 By Molly Wen
The Bamboo Works
60%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
1
Apr
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
4.5
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
About Prenetics Global Limited
Sector
Health Care
Industry
Health Care Providers & Services
Prenetics Global Ltd is a diagnostic and genetic testing company. It is a genomics and precision onc...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
PRE
WGS

FAQ

Q

How do I buy Prenetics Global (PRE) stock?

A

You can purchase shares of Prenetics Global (NASDAQ: PRE) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Prenetics Global's (PRE) competitors?

A

Other companies in Prenetics Global’s space includes: GeneDx Hldgs (NASDAQ:WGS), ATI Physical Therapy (NYSE:ATIP), Star Equity Hldgs (NASDAQ:STRR), Novo Integrated Sciences (NASDAQ:NVOS) and EUDA Health Holdings (NASDAQ:EUDA).

Q

What is the target price for Prenetics Global (PRE) stock?

A

The latest price target for Prenetics Global (NASDAQ: PRE) was reported by Cantor Fitzgerald on Thursday, April 4, 2024. The analyst firm set a price target for 9.00 expecting PRE to rise to within 12 months (a possible 149.31% upside). 4 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Prenetics Global (PRE)?

A

The stock price for Prenetics Global (NASDAQ: PRE) is $3.61 last updated Today at April 16, 2024 at 8:18 AM EDT.

Q

Does Prenetics Global (PRE) pay a dividend?

A

A quarterly cash dividend of $0.70 per share of Class A Common Stock. The quarterly cash dividend was payable on March 1, 2016 to stockholders of record on February 17, 2016.

Q

When is Prenetics Global (NASDAQ:PRE) reporting earnings?

A

Prenetics Global’s Q1 earnings are confirmed for Monday, June 3, 2024.

Q

Is Prenetics Global (PRE) going to split?

A

There is no upcoming split for Prenetics Global.

Q

What sector and industry does Prenetics Global (PRE) operate in?

A

Prenetics Global is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.

People Also Watch